Myocardial ischaemia reperfusion injury and cardioprotection in the presence of sensory neuropathy: Therapeutic options

被引:19
作者
Bencsik, Peter [1 ,2 ]
Gomori, Kamilla [1 ,2 ]
Szabados, Tamara [1 ,2 ]
Santha, Peter [3 ]
Helyes, Zsuzsanna [4 ,5 ]
Jancso, Gabor [3 ]
Ferdinandy, Peter [2 ,6 ]
Gorbe, Aniko [1 ,2 ,6 ]
机构
[1] Univ Szeged, Dept Pharmacol & Pharmacotherapy, Cardiovasc Res Grp, Fac Med, Dom Ter 12, H-6720 Szeged, Hungary
[2] Pharmahungary Grp, Szeged, Hungary
[3] Univ Szeged, Dept Physiol, Fac Med, Szeged, Hungary
[4] Univ Pecs, Med Sch, Dept Pharmacol & Pharmacotherapy, Pecs, Hungary
[5] Univ Pecs, Mol Pharmacol Res Grp, Ctr Neurosci, Janos Szentagothai Res Ctr, Pecs, Hungary
[6] Semmelweis Univ, Dept Pharmacol & Pharmacotherapy, Budapest, Hungary
关键词
GENE-RELATED PEPTIDE; CARDIOVASCULAR AUTONOMIC NEUROPATHY; IMPAIRS POSTISCHEMIC RECOVERY; MOUSE MODEL; HEART-FAILURE; ISCHEMIA/REPERFUSION INJURY; SELECTIVE DEGENERATION; PERIPHERAL NEUROPATHY; CARDIAC INNERVATION; CAPSAICIN RECEPTOR;
D O I
10.1111/bph.15021
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
During the last decades, mortality from acute myocardial infarction has been dramatically reduced. However, the incidence of post-infarction heart failure is still increasing. Cardioprotection by ischaemic conditioning had been discovered more than three decades ago. Its clinical translation, however, is still an unmet need. This is mainly due to the disrupted cardioprotective signalling pathways in the presence of different cardiovascular risk factors, co-morbidities and the medication being taken. Sensory neuropathy is one of the co-morbidities that has been shown to interfere with cardioprotection. In the present review, we summarize the diverse aetiology of sensory neuropathies and the mechanisms by which these neuropathies may interfere with ischaemic heart disease and cardioprotective signalling. Finally, we suggest future therapeutic options targeting both ischaemic heart and sensory neuropathy simultaneously.
引用
收藏
页码:5336 / 5356
页数:21
相关论文
共 163 条
[1]   Hereditary transthyretin amyloidosis: a model of medical progress for a fatal disease [J].
Adams, David ;
Koike, Haruki ;
Slama, Michel ;
Coelho, Teresa .
NATURE REVIEWS NEUROLOGY, 2019, 15 (07) :387-404
[2]  
Agashe Shruti, 2018, Methodist Debakey Cardiovasc J, V14, P251, DOI 10.14797/mdcj-14-4-251
[3]  
Alexander SPH, 2019, BRIT J PHARMACOL, V176, pS297, DOI [10.1111/bph.14752, 10.1111/bph.14749]
[4]   TRPA1 is functionally co-expressed with TRPV1 in cardiac muscle: Co-localization at z-discs, costameres and intercalated discs [J].
Andrei, Spencer R. ;
Sinharoy, Pritam ;
Bratz, Ian N. ;
Damron, Derek S. .
CHANNELS, 2016, 10 (05) :395-409
[5]  
Annapurna Akula, 2008, Exp Clin Cardiol, V13, P66
[6]   Translational neurocardiology: preclinical models and cardioneural integrative aspects [J].
Ardell, J. L. ;
Andresen, M. C. ;
Armour, J. A. ;
Billman, G. E. ;
Chen, P. -S. ;
Foreman, R. D. ;
Herring, N. ;
O'Leary, D. S. ;
Sabbah, H. N. ;
Schultz, H. D. ;
Sunagawa, K. ;
Zucker, I. H. .
JOURNAL OF PHYSIOLOGY-LONDON, 2016, 594 (14) :3877-3909
[7]   Animal models of rheumatoid arthritis [J].
Asquith, Darren L. ;
Miller, Ashley M. ;
McInnes, Iain B. ;
Liew, Foo Y. .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2009, 39 (08) :2040-2044
[8]   Vanilloid receptor agonists and antagonists are mitochondrial inhibitors: How vanilloids cause non-vanilloid receptor mediated cell death [J].
Athanasiou, Andriani ;
Smith, Paul A. ;
Vakilpour, Sara ;
Kumaran, Nethia M. ;
Turner, Amy E. ;
Bagiokou, Dimitra ;
Layfield, Robert ;
Ray, David E. ;
Westwell, Andrew D. ;
Alexander, Stephen P. H. ;
Kendall, David A. ;
Lobo, Dileep N. ;
Watson, Susan A. ;
Lophatanon, Artitaya ;
Muir, Kenneth A. ;
Guo, De-an ;
Bates, Timothy E. .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2007, 354 (01) :50-55
[9]   Resting heart rate and the risk of cardiovascular disease, total cancer, and all-cause mortality - A systematic review and dose-response meta-analysis of prospective studies [J].
Aune, D. ;
Sen, A. ;
o'Hartaigh, B. ;
Janszky, I. ;
Romundstad, P. R. ;
Tonstad, S. ;
Vatten, L. J. .
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2017, 27 (06) :504-517
[10]   Diagnosis and treatment of the cardiovascular consequences of Fabry disease [J].
Baig, S. ;
Vijapurapu, R. ;
Alharbi, F. ;
Nordin, S. ;
Kozor, R. ;
Moon, J. ;
Bembi, B. ;
Geberhiwot, T. ;
Steeds, R. P. .
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2019, 112 (01) :3-9